DRI Capital Inc. Updates Executive Changes

TORONTO, September 27, 2024  – DRI Healthcare Trust recently announced that its investigation into consulting and other expenses submitted had substantially concluded. DRI did not find Chris Anastasopoulos to have submitted any inappropriate consulting or other expenses. Mr. Anastasopoulos has since advised DRI Capital that he has decided to resign to pursue other opportunities. He will remain with DRI Capital to assist with a transition period to October 31, 2024.

DRI Capital wishes Mr. Anastasopoulos well in his future endeavours and thanks him for his contributions.

Recent Posts

DRI Healthcare Trust Comments on FDA Delay for KalVista Pharmaceuticals' Sebetralstat PDUFA Goal Date Due to FDA Reso...

DRI Healthcare Trust Announces Appointment of Annalisa King to Board of Trustees and as Chair of the Audit Committee

2025 First Quarter Earnings Call